A very long, winding road: Developing novel therapeutics for metastatic tumors
“Given that the MET inhibitor capmatinib caused a remarkable response in Dr. Blagosklonny, a pertinent question remains as to why he was not treated with ‘preemptive drug combinations’ […]” Credit: 2024 Dent. “Given that the MET inhibitor capmatinib caused a remarkable response in Dr. Blagosklonny,